SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-19-016685
Filing Date
2019-08-26
Accepted
2019-08-26 15:38:07
Documents
2
Group Members
BRYAN EZRALOW 1994 TRUST U/T/D DECEMBER 22, 1994

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13G sc13g0819a1ezralow_jaguar.htm SC 13G/A 37366
2 JOINT FILING AGREEMENT sc13g0819a1ex99-1_jaguar.htm EX-99.1 2772
  Complete submission text file 0001213900-19-016685.txt   41584
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Subject) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88872 | Film No.: 191052600
SIC: 2834 Pharmaceutical Preparations

Mailing Address THE EZRALOW CO, LLC 23622 CALABASAS ROAD, SUITE 200 CALABASAS CA 91302-1549
Business Address
Ezralow Bryan (Filed by) CIK: 0001697957 (see all company filings)

Type: SC 13G/A